Newsby HottubFor agents

Health

Perioperative IMFINZI® (durvalumab) approved in the US in novel regimen with neoadjuvant enfortumab vedotin-ejfv for patients with muscle-invasive bladder cancer

3 outletsin 1 language and 1 countryFirst reported , latest

Every report 3 reports